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HIGHLIGHTS 
 
 -Electrochemical biosensors demonstrated to be an excellent analytical tool 
to quantify miRNAs. 














MicroRNAs (miRNAs) are non-coding regulatory RNAs that play an important role 
in RNA silencing and post-transcriptional gene expression regulation. Since their 
dysregulation has been associated with Alzheimer disease, cardiovascular 
diseases and different types of cancer, among others, miRNAs can be used as 
biomarkers for early diagnosis and prognosis of these diseases. The methods 
commonly used to quantify miRNAs are, in general, complex, costly, with limited 
application for point-of-care devices or resource-limited facilities. Electrochemical 
biosensors, mainly those based on nanomaterials, have emerged as a promising 
alternative to the conventional miRNA detection methods and have paved the way 
to the development of sensitive, fast, and low-cost detection systems. This review 
is focused on the most relevant contributions performed in the field of 
electrochemical miRNAs biosensors between 2017 and the beginning of 2020. The 
main contribution of this article is the critical discussion of the different amplification 
strategies and the comparative analysis between amplified and non-amplified 
miRNA electrochemical biosensing and between the different amplification 
schemes. Particular emphasis was given to the importance of the nanostructures, 
enzymes, labelling molecules, and special sequences of nucleic acids or 
analogues on the organization of the different bioanalytical platforms, the 










1. General considerations about microRNAs 
 microRNAs (miRNAs) belong to a class of non-coding RNAs of 19-25 
nucleotides in length that present an important role in the post-transcriptional 
regulation of gene expression [1]. They are crucial regulators of cell differentiation, 
proliferation, apoptosis and immune response [2, 3]. According to miRBase, there 
are 1917 miRNAs encoding sequences identified in the human genome [1]. The 
biogenesis of miRNA is a multi-step process that starts within the nucleus through 
the action of RNA polymerase II that produces primary miRNA transcripts (pri-
miRNAs) of different lengths from the non-coding fraction of the genome.  The pri-
miRNA is cleaved by a microprocessor complex integrated by a RNase III enzyme 
(Drosha) and a RNA binding protein called DiGeorge syndrome critical region gene 
8 (DGCR8/Pasha), producing the precursor or premature miRNA (pre-microRNA) 
which contains 60–70 nucleotides. Pre-microRNA is then carried into the 
cytoplasm by exportin-5 (XPO5) and RanGTPase where the endonuclease called 
Dicer removes the terminal loops, originating the mature double-stranded 
microRNA (22 nucleotides long). One strand (passenger strand/complementary 
strand) is destroyed by Argonaute proteins while the other strand (guide 
strand/mature strand) is associated with RISC (RNA-induced silencing complex). 
The mature miRNA interacts with 3′ untranslated region (UTR) of target mRNA by 
one of two mechanisms of gene regulation depending on the degree of 
complementarity between miRNA and mRNA, either degradation of messenger 
RNA (mRNA) or repression of mRNA translation. An efficient complementarity 
leads to mRNA degradation, whereas a limited complementarity guides repression 









the cellular microenvironment, some others, called circulating/extracellular 
miRNAs, can be also detected in the extracellular environment, including several 
fluids like colostrum; breast milk; cerebrospinal, peritoneal, amniotic, synovial, 
pleural, follicular and seminal fluids; tears; saliva; bronchial lavage; urine; plasma 
and serum [4, 5]. Circulating miRNAs are present in exosomes, microvesicles, 
apoptotic bodies, complexes with Argonaut proteins, and complexes with high-
density lipoproteins to be protected from the RNases degradation [5]. miRNAs play 
a key role in the regulation of processes related to the development of numerous 
human diseases such as cancer, cardiovascular, immunological, 
neurodegenerative, and skin diseases [1, 5-11]. Therefore, they can be regarded 
as minimally invasive disease biomarkers, useful for the diagnosis, prognosis and 
treatment of different diseases, with special emphasis in cancer [5-11].   
 At present, miRNA detection techniques mostly rely on conventional 
nucleic acid detection assays such as the quantitative reverse transcription 
polymerase chain reaction (qRT-PCR), the gold standard technique; microarrays; 
Northern blot and RNA-sequencing [12-14]. Despite the excellent analytical 
performance offered by these techniques, they are complex and expensive and 
involve long detection processes. Therefore, they are not suitable for resource-
limited facilities and decentralized settings, restricting their real-world application. 
That is the reason why in the last years there has been an increasing interest for 
developing different biosensing strategies that make possible the highly sensitive 
and selective quantification of miRNAs [15, 16].  However, their low abundance, 
short length and high sequence similarity with other family members, have made 









electrochemical sensors offer many advantages in terms of sensitivity, selectivity, 
cost, robustness, portability, compatibility with point-of-care (POC) devices, and 
large-scale production [18-21]. Particularly, the combination of the electrochemical 
sensing with Nanobiotechnology, has generated a new class of low-cost, robust, 
reliable, easy-to-use and ultrasensitive tool for diagnostics and prognosis of 
several diseases [21].  
 
2. Electrochemical miRNAs biosensors  
 The most recent electrochemical biosensing schemes for miRNAs have 
been focused on the evaluation of the DNA-RNA or RNA-RNA duplexes formation 
mainly through the variation of the charge transfer resistance; the changes of the 
voltammetric, (chrono)amperometric or chronocoulometric response of different 
redox markers (either small electroactive compounds, inorganic complexes, redox 
mediators or intercalators), associated with nanomaterials and signaling enzymes. 
In the last years, the investigation of new amplification schemes has opened new 
horizons in the design of sensitive miRNAs biosensors. The main goal of these 
new developments was the generation of alternatives to qRT-PCR since, as it was 
already mentioned, in spite of its excellent analytical performance, it presents some 
draw-backs connected with the cost, time, and requirement of trained personal and 
special equipment. The engineering of different nucleic acid structures has become 
an interesting tool to increase the sensitivity of miRNA determinations. In this 
sense, the hybridization chain reaction (HCR), catalyzed hairpin-assembly (CHA) 









(SDA), and the recycling of target nucleic acids using endonucleases, have been 
the most widely used strategies.  
 In the following sections we present the most significant contributions 
performed in the last three years on the field of miRNA electrochemical biosensors, 
with a critical discussion about the amplification strategy, the bioanalytical platform 
and the transduction scheme. Table 1 summarizes the most relevant information 
for the different biosensors discussed in the manuscript.  
 
2. 1. Amplification-based electrochemical miRNAs biosensors 
 In this section we discuss the characteristics of the most representative 
miRNAs electrochemical biosensors organized according to the amplification 
strategy used to quantify the different miRNAs.  
 
2.1.a. Amplification schemes based on the facilitated accumulation of redox 
markers   
 One relatively simple, fast and sensitive amplification approach was 
focused on the electrostatic accumulation of a redox marker at the miRNA 
adsorbed at the electrode or at the resulting surface heteroduplex capture-
DNA/RNA. Islam et al. [22] reported the use of SPCEs modified with graphene 
oxide(GO)-loaded iron oxide for the quantification of miRNA-21 at fM level, through 
the adsorption of purified and magnetically separated miRNA at GO, the 
accumulation of [Ru(NH3)6]3+ (RuHex) at the negatively charged sugar-phosphate 
backbone of the nucleic acid, and its chronocoulometric detection catalyzed by 









and selective electrocatalytic detection of miRNA-107 at Au-loaded nanoporous 
superparamagnetic-iron oxide nanocubes-modified-SPCE through the catalytic 
reduction of RuHex electrostatically accumulated at the gold-adsorbed miRNA, 
allowing the sub-fM detection and the successful application for the quantification 
in cancer cell lines and samples of oesophageal squamous cell carcinoma. Su et 
al. [24] proposed the detection of sub-fM levels of miRNA-21 based on the use of 
gold nanoparticles (AuNPs)-decorated MoS2 nanosheets (AuNPs@MoS) in two-
directions, as platform for the immobilization of capture DNA and as signal-
amplifier and support for the signaling DNA. The miRNA-21 sandwich hybridization 
scheme was stablished between capture DNA-AuNPs@MoS2 and signaling DNA-
AuNPs@MoS2, and the analytical signal was obtained either, from the 
voltammetric (Differential Pulse Voltammetry, DPV) reduction current of the 
preconcentrated RuHex or from the increment in the charge transfer resistance of 
[Fe(CN)6]3-/4- (Figure 2). Ganguly et al. [25] reported the sub-fM non-labeled 
chronocoulometric detection of miRNA-21 through the redox signal of RuHex 
electrostatically accumulated at the hybrid generated between the thiolated capture 
DNA immobilized at MoS2 nanosheets intimately coupled with electrodeposited 
AuNPs (AuNPs@MoS2), the target miRNA-21, and the non-labeled signaling DNA.  
  
2.1.b. Amplification schemes based on the use of endonucleases 
The use of endonucleases associated with diverse nanostructures, 
(bio)catalytic processes and transduction schemes, has received great attention for 
the development of novel amplified miRNAs biosensing platforms. The most widely 









cleaves double stranded DNAs, or DNAs in DNA-RNA duplexes with at least 15 
base pairs, although is inactive to cleave single-stranded DNA, RNA or double 
stranded RNA [26].  
One interesting strategy was focused on the use of a thiolated capture DNA-
1-modified Au electrode as bioanalytical platform to detect miRNA-29a-3p through 
the DSN-mediated hydrolysis of the DNA-1 strand at the (DNA-1/miRNA-29a-3p) 
surface heteroduplex, the cyclic release of miRNA, the generation of more DNA-
RNA heteroduplexes, the decrease of the amount of DNA-1 available to hybridize 
with DNA-2-AuNPs, and the consequent decrease of the amount of RuHex 
electrostatically associated to the (DNA-1/DNA-2-AuNPs) (Figure 3) [27]. Bo et al. 
[28] reported an attomolar-level biosensing scheme for the quantification of 
miRNA-21 based on the use of a thiolated hairpin probe-modified Au electrode as 
platform to generate a surface heteroduplex in the presence of miRNA-21 that 
triggers the cyclic cleavage of the DNA strand mediated by DSN, the final 
hybridization between the remaining surface-DNA with the bridge signaling DNA-
AuNPs, and further preconcentration of RuHex, responsible for the 
chronocoulometric reduction signal (Figure 4). Another biomarker used to quantify 
miRNA in connection with the use of DSN, was the anticancer drug doxorubicin. 
Tao et al. [29] described the ultrasensitive quantification of miRNA-let-7d through 
the use of a double-loop hairpin probe that possesses a capture sequence, an 
output segment and its complementary fragment immobilized at the electrode, in 
association with the signaling AuNPs@Dox@S1. In the presence of miRNA-let-7d 
the surface heteroduplex generated with the capture sequence allows the action of 









AuNPs@Dox@S1, and producing a decrease in the voltammetric (square wave 
voltammetry, SWV) response of doxorubicin. Other DSN-based amplification 
strategies were focused on the transduction of the hybridization event from the 
electrochemical detection of the biocatalytic activity of labelling enzymes like 
horseradish peroxidase (HRP) and alkaline phosphatase (ALP). Figure 5A shows 
an interesting biosensing scheme for the attomolar detection of miRNA-21 
proposed by Zhang H et al. [30] which involves a triple signal amplification 
associated with the use of a hairpin DNA modified-gold electrode, the action of 
DSN-assisted target recycling, and the incorporation of a biotinylated signaling 
DNA/streptavidin-AuNPs to anchor the biotinylated HRP. Figure 5B shows the 
typical voltammetric profiles of 3,3,5,5´tetramethylbenzidine (TMB) obtained in the 
presence of miRNA-21 due to the biocatalytic activity of the HRP incorporated in 
the multistructure, effect that is more pronounced as the concentration of the 
biomarker increases due to the higher accumulation of HRP Figure 5C depicts the 
corresponding chronoamperograms for the addition of increasing concentration of 
miRNA-21. Wang J. et al. [31] presented the immobilization of a capture DNA at 
bMWCNTs@GOnanoribons@AuNPs-modified GCE, the cyclic DSN-mediated 
cleavage of the heteroduplex generated in the presence of miRNA, and further 
association of the streptavidin-ALP conjugate that generates ascorbic acid from 
ascorbic-acid phosphate and produces the reduction of iodine. The higher the 
concentration of miRNA, the lower the amount of the biotinylated signaling DNA at 
the electrode surface and the lower the analytical signal.  Miao et al. [32] reported 
the use of another endonuclease to develop an interesting alternative for the 









trigon structure and endonuclease-mediated signal amplification using a GCE 
modified with poly(diallyldimethylammonium chloride) (PDDA) and AuNPs to 
anchor the MB-labeled-capture probe.  Since the capture and auxiliary probes 
were partially complementary to the miRNA, a star-trigon structure was formed on 
the electrode surface and, in the presence of the endonuclease Nb.BbvCI, the 
(capture probe/auxiliary probe)-duplex is cleaved. After this cleavage, the released 
miRNA can form another star-trigon with other capture probe molecules producing, 
in this way, an amplification cycle and a large decrease of the MB electrochemical 
signal.  
 
2.1.c. Amplification schemes based on DNA displacement reactions 
Another amplification strategy was focused on the double-stranded DNA 
displacement reaction. Wang et al. [33] reported a biosensor for miRNA-24 using a 
platform of GCE modified by electrodeposition of cobalt oxide petals and poly(o-
phenylenediamine) and covalent attachment of hyaluronic acid and methionine-
gold nanoclusters as support for the “partial” probe/MB-reporter double strand. 
Since the sequence of MB-reporter is not exactly complementary to the probe, the 
miRNA-24 produces the displacement of the MB-reporter with the consequent 
decrease of MB-amperometric signal.  
 
2.1.d. Amplification schemes based on special nucleic acids structures 
 Hairpins, molecular beacons, locked nucleic acids, and G-quadruplexes 
have been also used for the development of miRNAs bioanalytical platforms, taking 









the voltammetric and impedimetric attomolar quantification of miRNA-141 using a 
GCE modified with AuNPs and a hairpin-locked DNAzyme which was opened in 
the presence of miRNA-141, yielding the “active” DNAzyme that, after cleavage by 
Mg2+, releases the target and generates successive activation cycles. The 
remaining fragment on the electrode surface collects numerous CuCo−CeO2-
signaling DNA bioconjugates and, in this way, the biosensing platform offers the 
great advantage of having two analytical signals, the voltammetric response of the 
hydrogen peroxide reduction and the charge transfer resistance due to the non-
soluble nature of 3,3-diaminobenzidine (DAB) oxidation product. Azzouzi et al. [35] 
proposed an impedimetric biosensor for sub-pM quantification of micro RNA-21 
which relies on the use of GCE modified with neutravidin and a highly specific 
biotinylated DNA/Locked nucleic acid (LNA) molecular beacon-probe conjugated 
with AuNPS.  The hybridization with miRNA-21 allows the activation of biotin and 
the collection of the biotinlylated multistructure at the glassy carbon platform, 
decreasing the charge transfer resistance of [Fe(CN)6]3-/4-. Ren et al. [36] reported 
an electrochemical sensor for non-labeled quantification of miRNA-let-7-a through 
the formation of trivalent DNAzyme junctions by catalytic hairpin assembly (CHA). 
The target can lead to CHA of three hairpins into many trivalent DNAzyme 
junctions that cleave more efficiently the surface G-quadruplex-containing DNA 
and allow the binding of hemin, with the consequent enhancement of the 
associated current in the presence of hydrogen peroxide. Miao et al. [37] described 
a very interesting strategy for the fM detection of miRNA-21 by using sandwich 
hybridization at a capture probe-modified gold surface, and a signaling probe rich 









signaling probe is transformed in G-quadruplex, allowing the specific interaction of 
the Ir(III) complex that works as peroxidase mimics, catalyzing the reduction of 
hydrogen peroxide, and increasing the voltammetric signal of the redox mediator 
MB. Huang et al. [38] described a highly sensitive electrochemical biosensor for 
miRNA which relied on the use of tetrahedral DNA nanostructure probes and 
guanine nanowire amplification. In the presence of miRNA, the hairpin of one of the 
branches of the tetrahedral is opened, the stem sequence of the hairpin is 
released, and the generated G-quadruplex induces the construction of a guanine 
nanowire. After the addition of hemin, and in the presence of hydrogen peroxide, 
the G-quadruplex-hemin repeat units catalyzes the oxidation of TMB (Figure 6). An 
original strategy focused on the use of a bipedal DNA, was proposed for the 
ratiometric attomolar quantification of exosomal miRNA-21 [39]. The DNA walker 
released after magnetic separation of streptavidin-magnetic beads/capture 
DNA/DNA walker/miRNA-21 is dropped at the biorecognition platform of GCE-
AuNPs modified by immobilization of a hairpin-MB producing a conformational 
change in the hairpin-1 that makes possible the hybridization with the hairpin-2 
modified with Fc. As a consequence of that, the DNA walker starts to walk and, 
finally, both redox markers, MB and Fc, remain close to the electrode surface, 
making easier the charge transfer and increasing the ratio Fc current/MB current 
with the increment of miRNA-21 concentration.   
 
2.1.e. Amplification schemes based on hybridization chain reaction  
 Hybridization chain reaction (HCR) is an excellent amplification technique 









at variance with other isothermal amplification techniques like rolling change 
amplification (RCA), ligase chain reaction (LCR), or the use of nuclease digestion, 
which need the assistance of specific enzymes. Several strategies have been 
proposed for the development of HCR-based miRNA biosensors. Cheng et al. [40] 
reported the enzyme-free amplification for miRNA-21 biosensing using 
mesoporous silica containers (MSNs), CHA and HCR. The analytical signal was 
obtained from the SWV signal of the MB released from mesoporous silica 
nanospheres-hairpin H1 and then intercalated within the duplex generated at the 
gold electrode/capture-DNA after H1-miRNA-21 hybridization as a consequence of 
HCR and CHA in the presence of the hairpin H2 (Figure 7). Feng et al. [41] 
proposed a thiol-hairpin-capture probe modified gold electrode, which suffers a 
conformational change in the presence of miRNA-21 and triggers HCR to generate 
a long DNA strand that allows an enhancement in SWV signals of the 
molybdophosphate generated by accumulation of molybdate at the DNA 
phosphate residues. Guo et al. [42] described the sub-fM detection of miRNA-21 
through the combination of a dual signal amplification strategy that involves HCR to 
expand the miRNA-21 into a longer structure and provides more sites for the 
enzyme induced metallization (EIM). The conjugates generated at the magnetic 
nanobeads modified with the capture probe allowed the association of a high 
number of conjugates containing ALP, which in the presence of p-aminophenyl 
phosphate (p-APP) produces p-aminophenol that reduces the Ag+ deposited at the 
electrode surface, enhancing the Ag anodic stripping signal (Figure 8A). Figure 8B 
clearly demonstrates the advantages of the elongation and the labelling of the 









[43] proposed the determination of microRNA-21 at aM level using a hairpin 
capture probe immobilized at Fe3O4, which is opened after hybridization with 
miRNA-21 while the exposed portion of the hairpin-capture probe opens two 
alternating HDNA, propagating a HCR and forming a nicked double helix that 
allows the accumulation of the planar Cu(II) complex. The analytical signal was 
obtained through the synergized catalytic reduction of hydrogen peroxide/TMB 
system due to the action of the copper complex and Fe3O4.  Liang et al. [44] 
described a label-free and enzyme-free detection of miRNA-21 at pM levels using 
an isothermal amplification scheme based on cascade-HCR and different 
electrochemical transduction approaches, EIS using [Fe(CN)6]3-/4-, DPV in 
connection with the intercalation of MB in the hyper-branched resulting dsDNA, 
and chronocoulometry using RuHex. The miRNA captured at the thiolated 
biorecognition DNA-modified gold electrode initiates autonomous assembly of DNA 
nanostructures through the toehold-mediated strand displacement reaction and the 
resulting cascade HCR, producing the extended growth of DNA chains and higher 
amplification efficiency compared to the regular HCR.  
 Yuan et al. [45] reported a biosensor for the simultaneous detection of 
pancreatic cancer biomarkers, miRNA-141 and miRNA-21, by taking advantage of 
the use of Fe3O4-NPs modified with two different redox markers, thionine (Thi) and 
ferrocene carboxaldehyde (Fc), and target-triggered HCR. In the presence of the 
corresponding miRNAs, the thiol-modified hairpin capture probes (HCP1 and 
HCP2) immobilized at Au, hybridize with miRNA-141 and miRNA-21, leading to the 
conformational change of these probes that trigger HCR and produce the capture 









currents associated with the oxidation of the redox markers allowed the 
simultaneous quantification of miR-141 and miR-21, with successful application in 
cell lysates. Bao et al. [46] proposed an interesting alternative for miRNA-16-
amplified biosensing through the association of a nanocomposite platform to build 
the biorecognition layer, CHA to obtain the double helix, and HCR to elongate the 
DNA strands and facilitate the intercalation of the redox marker. The bioanalytical 
platform was obtained by integrating AuNPs/polypyrrole-reduced GO (Au/PPy-
rGO) at GCE to amplify the electrochemical signal and to support the thiolated 
capture probe (Figure 9 A and B). The final electrochemical transduction was 
performed by DPV of the intercalated MB as indicated in Figure 9C. The 
corresponding calibration plot is depicted in Figure 9D, with a very wide linear 
range and a fM detection of miRNA-16.  
 
2.1.f. Amplification schemes based on catalyzed hairpin assembly  
 Zhang K. et al. [47] proposed the combination of a supramolecular 
sensing architecture based on ZrO2-RGO modified electrode and CHA for the very 
sensitive detection of miRNA-21. The platform was obtained by immobilization of 
ZrO2-RGO, followed by the covalent attachment of the capture RNA (hairpin 1), 
which, in the presence of the target, hybridizes and opens the hairpin H2, releasing 
the miRNA and allowing the incorporation of H2 to the electrode in a cyclic way 
through CHA. The amplified charge transfer resistance of [Fe(CN)6]3-/4- was used 
as analytical signal allowing the detection of fM levels. Li et al. [48] proposed a 
ratiometric scheme based on target driven CHA mismatched using three hairpins, 









the gold electrode. Due to the mismatches, the hybridization between H1 and H2 is 
not very efficient, and in the presence of the target miRNA-21, the strand 
displacement occurs, exposing the portion complementary to H2, and allowing the 
H1-H2 hybridization. In this way, miRNA-21 is released and cyclically hybridizes 
with more H1. Finally, the exposed portion of H1-H2 duplex hybridizes with H3, 
leaving the MB far away and Fc close to the electrochemical interface, making 
possible the fM detection of the hybridization from the increment in the 
voltammetric signal of Fc and the decrease of the MB one (Figure 10).  
2.1.g. Other amplification schemes  
 Mandli et al. [49] proposed the use of sandwich hybridization onto AuNPs-
modified PGE and the detection using a conjugate ALP-Streptavidin from the 
naphthol oxidation signal in the presence of α-naphthyl phosphate. Deng et al. [50] 
described a sandwich hybridization between capture DNA-AuNPs, miRNA-21 and 
MWCNTs modified with a signaling DNA and labeled with thionine. Therefore, the 
presence of miRNA-21 was determined from the voltammetric signal of thionine, 
which increases with the concentration of the target, being the detection limit 0.032 
pM. Liu et al. [51] reported a sandwich electrochemical exosomal microRNA-21 
sensor (SEEmiR) using peptide nucleic acid as biorecognition element and 
spherical DNA (SNA) as secondary probe. The hybridization signal was obtained 
from the chronocoulometric response of RuHex, with a detection limit of 49 aM 
(Figure 11A). The increment of the voltammetric and chronocoulometric signals for 
RuHex in the presence of SNA clearly demonstrate the importance of the SNA-
mediated amplification (Figure 11B). These advantages are also evident from the 









free and enzyme-independent miRNA detection in cell lysates, unpurified tumor 
exosomal lysates and blood of cancer patients.  
 A simple scheme was recently described by Zouari et al. [52] for the 
quantification of miRNA-21 at fM level through the sandwich hybridization between 
the thiolated-DNA probes at SPCE modified with GO-AuNPs nanohybrid and the 
signaling DNA conjugated with Fc-AuNPs-Streptavidin, being Fc the responsible of 
the analytical signal (Figure 11).    
 Zhang C. et al. [53] described the attomolar and label-free electrochemical 
miRNA-21 biosensor based on RCA that produces a massive G-rich long ssDNA to 
be used as matrix for the in situ synthesis of PdNPs based on the interaction of 
Pd(II) with the nitrogen atoms of guanine residues, enhancing the electrochemical 
signal.  
 Vargas et al. [54] reported an innovative amperometric magneto-biosensor 
for the sub-pM detection of miRNA-21 by combining geno- and immunoassays 
through the use of magnetic beads modified with streptavidin as platform and 
detection at a magneto SPCE through the use of an anti DNA-RNA antibody and 
the bacterial protein A (ProtA) conjugated with a horseradish peroxidase (HRP) 
homopolymer (Poly-HRP40) as an enzymatic label for signal amplification in the 
presence of hydrogen peroxide and hydroquinone. 
 Cao et al. [55] proposed an electrochemical biosensor for the 
simultaneous detection of miRNA-155 and miRNA-122 based on covalent–organic 
framework (COF) nanowire synthesized via condensation polymerization of 
1,3,6,8-tetra(4-carboxylphenyl)pyrene and melamine (TBAPy-MA–COF–COOH) as 









anti-miRNA155 and anti-miRNA-22 modified with shell-encoded AuNPs as signal 
labels (AgNCs@AuNPs and Cu2O@AuNPs, respectively). In the presence of 
miRNA-122 and miRNA-155, the aptamers recognize them and are released from 
the electrode surface, with the consequent decrease in the DPV peak current 
density at -0.1 V (Cu2O@AuNPs) and 0.08 V (AgNCs@AuNPs) allowing the 
detection of fM and sub-pM levels for miRNA 155 and miRNA 122, respectively.  
 
 
2.1.h. Concluding remarks about amplification-based schemes 
 The analysis of the different amplification-based approaches for 
electrochemical miRNAs biosensing previously discussed, clearly demonstrate 
that, in general, and depending on the strategy, is possible to reach detection limits 
at sub-fM levels with relatively simple schemes, without involving enzymes or 
additional reactions, just using the electrochemical signal due to an electrostatically 
accumulated redox marker at the surface of adsorbed miRNA or surface-generated 
heteroduplex, with or without additional catalytic cycles. The association of 
endonucleases with electrochemical transduction, either using redox markers or 
enzymatic labelling, represents a very successful alternative to get more sensitive 
quantification of miRNAs, with extremely low detection limits in some of the 
approaches. However, is also important to remark that, at the same time that the 
system can be pushed-down to lower detection levels, these assay time 
considerably increases due to the higher number of steps involved in the protocol. 
Similar behavior is observed when using special structures of nucleic acids or 









complexes, metallic nanostructures or redox markers. The multiple possibilities to 
combine the signaling DNAs and/or markers gives to these strategies a great 
potential and the advantage of reaching extremely low detection limits. 
Nevertheless, as in the case of endonucleases-based protocols, despite the 
improved sensitive and selectivity, the processes are time-consuming. The 
simplest scheme is the sandwich hybridization, being the rational selection of the 
signaling probe label the most critical aspect to guarantee a good analytical 
performance. Thus, although the detection limits are not as low as in the other 
amplification-based protocols, their analytical characteristics of the sandwich 
hybridization schemes are very useful for the quantification of miRNAs in real 
samples, with the great advantage of the lower number of steps and shorter assay-
time.   
 
2.2. Non-amplified electrochemical miRNAs biosensors  
The results discussed in the previous section demonstrated that 
amplification-based electrochemical miRNAs biosensors present clear advantages 
mainly connected to the sensitivity and the possibility to reach extremely low 
detection limits, essential condition to detect circulating miRNAs.  However, in spite 
of the excellent analytical performance of these biosensors, the search for simple, 
sensitive, and selective miRNA biosensing schemes, that allow the faster, cheaper 
and easier quantification of miRNAs is still receiving great attention. In this section 










One interesting strategy has been the development of ratiometric 
biosensors focused on the electrochemical response of two redox markers, which 
was dependent on the distance from the electrode before and after the 
hybridization event. In this direction, Luo et al. [56] proposed the non-amplified fM 
ratiometric-detection of exosomal miRNA-21 based on the currents ratio of MB and 
Fc located in Y shape-like probe (generated at the polylysine-modified GCE) 
through the locked-nucleic acid (LNA)-assisted strand displacement reaction that 
takes place in the presence of the target (Figure 12).   
Pingarrón´s group reported an innovative biosensing scheme based on the 
competitive RNA-RNA hybridization using a AuNPs-modified SPCE as platform for 
the immobilization of capture RNA probe. The analytical signal was obtained from 
the changes in the amperometric response of the hydrogen peroxide/hydroquinone 
system which was dependent on the amount of streptavidin-HRP conjugate 
associated to the supramolecular architecture obtained after the competition 
between biotinylated-miRNA-21 and the target miRNA-21 (Figure 13) [57].  
 Kaplan et al. [58] described the use of PGE modified with the DNA probe 
entrapped in a matrix of electropolymerized polypyrrole for the non-labeled 
detection of miRNA-21 either, from the change in the charge transfer resistance of 
[Fe(CN)6]3-/4- or from the voltammetric reduction signal of the meldolla blue redox 
marker, with successful application in a breast cancer cell line. Another non-
labeled biosensing platform based on the use of PGE was proposed for the ppb 
level quantification of miRNA-660. It relied on the immobilization of a CHIT/nitrogen 
doped-RGO composite to support the probe and the transduction of the 









marker [Fe(CN)6]3-/4- [59]. Su et al. [60] described the sub-fM detection of miRNA-
21 using indium tin oxide (ITO) modified with hierarchical flower-like AuNPs as 
platform for the capture probe immobilization and voltammetric detection of the 
RuHex accumulated after hybridization, with successful application in human lung 
cancer cell (A549) lysates and serum. Bharti et al. [61] proposed a bioanalytical 
platform of fluorine tin oxide (FTO) modified with carboxylated-GO, 
electrodeposited AuPt-NPs and streptavidin to allow the anchorage of the 
biotinylated probe and the detection of miRNA-21 biorecognition event through the 
decrease of [Fe(CN)6]3-/4- DPV signal. 
 Su et al. [62] proposed the detection of miRNA-21 at fM level through the 
changes in the redox signal of MB at GCE containing MB-modified MoS2 before 
and after the formation of the DNA-miRNA-21 heteroduplex. Wang F. et al. [63] 
reported the fM detection of the hepatocellular carcinoma biomarker miRNA-122 
using Au modified with a thiolated-DNA probe, GO adsorbed through π-stacking 
and Prussian blue (PB) grown in situ at the GO layer. The analytical signal was 
obtained from the decrease of PB voltammetric response in the presence of 
miRNA, due to the differential affinity of GO with ssDNA and DNA-RNA. Following 
a similar scheme, Zhu et al. [64] reported the label-free and simple detection of 
miRNA-21, through the decrease of the SWV signal of thionin after hybridization 
with miRNA-21 at a GCE/MoS2-thionine-AuNPs. Tran et al.  [65] reported a label-
free and reagentless sensing of miRNA based on the use of a DNA probe-AuNPs-
modified GCE and 5-hydroxy-3-hexanedithiol-1,4-naphthoquinone, as indicator of 
the analytical signal. Tian et al. [66] proposed another label-free strategy that 









using polypyrrole-coated AuNPs as platform to immobilize the RNA probe, 
evaluating the hybridization event from the DPV oxidation signal of toluidine blue 
(TB) preferentially accumulated at the duplex. Kaugkamano et al. [67] described 
the voltammetric detection of miRNA-21 at fM levels through the decrease of Ag 
oxidation signal at Au modified with electropolymerized polypyrrole/Ag nanofoam 
and pyrrolidinyl-PNA as biorecognition element. Jeong et al. [68] presented the 
label-free quantification of miR-375 at aM level in pure buffer solution and fM level 
in metastatic prostate cancer cells using a simple non-amplified electrochemical 
transduction. The biosensing strategy was obtained by immobilization of a thiolated 
capture probe at Au followed by the hybridization and electrochemical transduction 
using the [Fe(CN)6]3−/4- SWV response.  
 These amplification-free miRNAs electrochemical biosensors, allows us to 
conclude that is possible to obtain a sensitive miRNA quantification even without 
amplification steps, greatly simplifying the analytical procedure and reducing the 
cost and the time of the assay. These biosensors present figures of merit really 
competitive compared to those based on amplification schemes, making them very 
interesting for several applications, like the implementation in low-resources 
settings.  
 
3. Conclusions and Perspectives  
The last years have witnessed a notable growth of the miRNA-biosensors 
field due to the increased knowledge of the clinical usefulness of miRNAs as 
biomarkers for the diagnosis, prognosis, and even therapy of relevant diseases, 









cancer and cardiovascular diseases.  This review summarized the most significant 
achievements in the development of electrochemical biosensors for the 
quantification of miRNAs reported between 2017 and the beginning of 2020. 
The electrochemical miRNA-biosensors presented here involve different 
probes (RNAs, conventional DNAs, hairpins, walker and tetrahedral DNAs, DNAs 
analogues), immobilized at diverse electrodes (GCE, PGE, SPCE, Au, ITO, FTO), 
combined with different nanomaterials (MoS2, CNTs, graphene derivatives, AuNPs, 
metallic nanoparticles) and nanomagnetic separation, associated with a variety of 
biorecognition/transduction strategies (sandwich hybridization; use of redox 
markers; labelled redox enzymes;  isothermal amplification schemes like HCR, 
CHA, RCA; endonucleases-based and strand displacement reactions), in 
connection with impedimetric, voltammetric, chronocoulometric or 
(chrono)amperometric detection.  
Even when the different amplification alternatives demonstrate clear 
advantages, the efficiency of non-amplified miRNA biosensing is also remarkable 
considering that they offer not only faster, simpler and cheaper quantification, but 
also analytical competitiveness. Further developments should consider the design 
of novel bioreceptors and new signaling schemes involving aptamers, lectins or 
antibodies with improved specificity towards RNA-DNA heteroduplexes. 
Most of the electrochemical miRNA-biosensors have demonstrated to be 
successful in biological fluids and cell lysates; however, one important aspect that 
requires special attention for the real clinical application of these biosensors and 
further incorporation in routine analysis, is the evaluation of a large cohort of 









successfully works even for patients with different coexisting pathologies, diverse 
health-state and under administration of a variety of medicines. The incorporation 
of under-expressed miRNAs like tumor suppressors in the battery of targets for 
electrochemical miRNA-biosensors is another important challenge that should be 
considered for further developments. Taking into account that, in general, the 
known miRNAs are not specific only for one pathology, special attention should be 
also paid to the development of electrochemical biosensors devoted to the 
simultaneous quantification of a panel of miRNAs to facilitate the diagnosis with 
improved reliability. 
 In summary, the electrochemical miRNA-biosensors field is flourishing, 
and has demonstrated an incredible evolution in the last decade in consonance 
with the increasing studies of basic aspects about the role of miRNAs. The new 
efforts and the new challenges should be focused on the development of point-of-
care devices able to address the requirements of the new dimensions of diagnosis 
in the Medicine of the future, overcoming the limitations in terms of portability, cost, 
and easy adaptability to a broad range of settings.    
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LEGENDS OF THE FIGURES 
 
Figure 1. Nuclear and cytoplasmic processing of miRNAs and mechanisms of 
gene expression regulation. Reprinted from Ref. [4], Copyright (2020), with 










Figure 2. Schematic of label-free and dual mode electrochemical assay for 
miRNA-21 detection based on gold-nanoparticle-decorated MoS2 nanosheet. 
Reprinted from Ref. [24], Copyright (2017), with permission from Elsevier.  
 
Figure 3. Scheme of the amplified detection of miRNA through the activity of DSN 
and the accumulation of the redox marker RuHex.  Reprinted from Ref. [27], 
Copyright (2016), with permission from Elsevier.  
 
Figure 4. Scheme for the triple amplified detection of miRNA with electrochemical 
quantification through the accumulation of the redox marker RuHex. Reprinted with 
permission from Ref. [28], Copyright (2018), American Chemical Society.  
 
Figure 5. A) Scheme of the electrochemical miRNA biosensor based on DSN-
assisted target recycling followed with AuNPs and HRP enzymatic signal 
amplification strategy. B) Cyclic voltammograms of the electrochemical biosensor 
monitoring the TMB redox reaction in the presence of: a) 0M, b) 100 fM, c) 100 pM 
miRNA-21. C) Chronoamperometric signals obtained for different concentrations of 
miRNA-21 a) to i) is 0.01fM, 1fM, 10 fM, 50 fM, 100 fM, 1 pM, 10 pM, 100, pM, 
respectively. The inset is the linear calibration plot of Δi versus the logarithm of 
miRNA-21 concentration. Adapted from Ref. [30], Copyright (2019), with 
permission from Elsevier.  
 
Figure 6. Schematic representation for the different steps during the building of the 
electrochemical miRNA biosensor and the electrochemical transduction. Adapted 
by permission from Springer Nature: Amperometric biosensor for microRNA based 
on the use of tetrahedral DNA nanostructure probes and guanine nanowire 
amplification, Huang, Y.L., Mo, S., Gao, Z.F., Chen, J.R., Lei, J.L., Luo, H.Q., Li, 
N.B., Copyright (2017)  
 
Figure 7. (A) Schematic diagram of MSNs and programmed CHA/HCR based 









response of the programmed CHA/HCR on SH−CP/MCH-modified AuE incubated 
with the mixtures of (a) MB@MSNs−DNA, H1, H2, and H4 probes, (b) target 
miRNA-21, MB@MSNs−DNA, and H2 probe, and (c) target miRNA-21, 
MB@MSNs−DNA, H2, H3, and H4 probes. MSNs, mesoporous silica containers; 
CHA, catalytic hairpin assembly; HCR, hybridization chain reaction; CP, capture 
probe; MCH, 6-mercaptohexanol; MB, methylene blue. Adapted with permission 
from Ref. [40]. Copyright 2019 American Chemical Society.  
 
Figure 8. (A) Schematic diagram of the protocol for electrochemical detection of 
miRNA-21: capture of miRNA-21 and HCR (above), and EIM and electrochemical 
detection of multiple samples on the same MA (below). (B) LSVs under different 
conditions: MBs / CP H1 / miRNA-21 / biotin-H2 (curve black), MBs / CP H1 / 
miRNA-21 / biotin-H2 / SA-ALP (curve red), and MBs / CP H1 / miRNA-21 / biotin-
H2 / biotin-H1 / SA-ALP (curve blue). HCR, hybridization chain reaction; EIM, 
enzyme-induced metallization; MA, AuNPs-modified ITO microelectrode array; 
MBs, magnetic nanobeads; CP, capture probe; SA-ALP, streptavidin-alkaline 
phosphatase conjugate. Adapted from Ref. [42], Copyright (2019), with permission 
from Elsevier.  
 
Figure 9. (A) Schematic diagram of the electrochemical miRNA biosensor based 
on enzyme-free signal amplification integrating rGO-PPy/AuNPs, CHA, and HCR. 
(B) Structures of H1, target, H2, H3, and H4, respectively. (C) DPVs for the 
detection of different concentrations of target microRNA with the proposed method. 
(D) The corresponding calibration plot obtained from the DPVs shown in (C). rGO, 
reduced graphene oxide; PPy, polypyrrole; AuNPs, gold nanoparticles; CHA, 
catalytic hairpin assembly; HCR, hybridization chain reaction. Adapted from Ref. 
[46], Copyright (2019), with permission from Elsevier.  
 
Figure 10. Scheme for the electrochemical quantification of miRNA-21 through the 
target-driven CHA and ratiometric amplification strategy. Reprinted from Ref. [48], 









Figure 11. (A) Schematic diagram of exosomal miRNA detection using a 
“sandwich” electrochemical exosomal miRNA sensor (SEEmiR). In the presence of 
target, electrode surface-assembled PNA probes specifically hybridize with 
SNA−miRNA complex. RuHex serves as an electroactive indicator by CC. (B) CVs 
(a) and CC curves (b) of the SEEmiR sensor assembled with PNA probe (gray 
line), after hybridization with miRNA in the absence (green line) and presence 
(orange line) of SNA after incubation with RuHex, respectively. ΔQ is the variation 
in the redox charge of RuHex before and after hybridization. (c) SWVs of PNA and 
DNA hybridization with miRNA-21 labeled with MB. From inset, PNA−miRNA 
shows a substantial signal enhancement over DNA−miRNA. (d) Optimization of 
assembly concentrations of PNA to obtain rational probe spacing at the interface 
and to maintain the maximal hybridization efficiency for SNA. (C) (a) CC curves of 
the SEEmiR sensor in response to different target miRNA-21 concentrations in the 
presence of SNA after incubation with RuHex. (b) ΔQ versus miRNA-21 
concentrations. (c) CC curves of the SEEmiR sensor in response to different target 
miRNA-21 concentrations without SNA amplification. (d) Linear relationship 
between ΔQ and the logarithm of target miRNA-21 concentrations in the presence 
(orange line) and absence (blue line) of SNA amplification, respectively. (d) SNA 
renders the sensitivity improvement by 3 orders of magnitude (gray box). PNA, 
peptide nucleic acid; SNA, spherical nucleic acid; RuHex, [Ru(NH3)6]3+; CC, 
chronocoulometry; MB, methylene blue. Adapted with permission from Ref. [51]. 
Copyright 2019 American Chemical Society. (2019) Analytical Chemistry, 91 (20), 
pp. 13198-13205 
 
Figure 12. Schematic illustration of the ratiometric electrochemical biosensor for 
exosomal miRNA-21 detection. Reprinted from Ref. [56], Copyright (2020), with 
permission from Elsevier.  
 
Figure 13. Schematic illustration of the preparation of the SH-RNA/MCH-AuNPs-
























Figure 1. Nuclear and cytoplasmic processing of miRNAs and mechanisms of gene 
expression regulation. Reprinted from Ref. [4], Copyright (2020), with permission 

























Figure 2. Schematic of label-free and dual mode electrochemical assay for miRNA-
21 detection based on gold-nanoparticle-decorated MoS2 nanosheet. Reprinted 






























Figure 3. Scheme of the amplified detection of miRNA through the activity of DSN 
and the accumulation of the redox marker RuHex.  Reprinted from Ref. [27], 












Figure 4. Scheme for the triple amplified detection of miRNA with electrochemical 
quantification through the accumulation of the redox marker RuHex. Reprinted from 



























Figure 5. A) Scheme of the electrochemical miRNA biosensor based on DSN-
assisted target recycling followed with AuNPs and HRP enzymatic signal 
amplification strategy. B) Cyclic voltammograms of the electrochemical biosensor 
monitoring the TMB redox reaction in the presence of: a) 0M, b) 100 fM, c) 100 pM 
miRNA-21. C) Chronoamperometric signals obtained for different concentrations of 









respectively. The inset is the linear calibration plot of Δi versus the logarithm of 
miRNA-21 concentration. Adapted from Ref. [30], Copyright (2019), with permission 
from Elsevier.  
 
 
Figure 6. Schematic representation for the different steps during the building of the 
electrochemical miRNA biosensor and the electrochemical transduction. Adapted by 
permission from Springer Nature: Amperometric biosensor for microRNA based on 
the use of tetrahedral DNA nanostructure probes and guanine nanowire 
amplification, Huang, Y.L., Mo, S., Gao, Z.F., Chen, J.R., Lei, J.L., Luo, H.Q., Li, 





















Figure 7. (A) Schematic diagram of MSNs and programmed CHA/HCR based 
electrochemical sensing platform for miRNA-21 ultrasensitive detection. (B) SWV 
response of the programmed CHA/HCR on SH−CP/MCH-modified AuE incubated 
with the mixtures of (a) MB@MSNs−DNA, H1, H2, and H4 probes, (b) target miRNA-
21, MB@MSNs−DNA, and H2 probe, and (c) target miRNA-21, MB@MSNs−DNA, 
H2, H3, and H4 probes. MSNs, mesoporous silica containers; CHA, catalytic hairpin 
assembly; HCR, hybridization chain reaction; CP, capture probe; MCH, 6-
mercaptohexanol; MB, methylene blue. Adapted with permission from Ref. [40]. 



















Figure 8. (A) Schematic diagram of the protocol for electrochemical detection of 
miRNA-21: capture of miRNA-21 and HCR (above), and EIM and electrochemical 
detection of multiple samples on the same MA (below). (B) LSVs under different 
conditions: MBs / CP H1 / miRNA-21 / biotin-H2 (curve black), MBs / CP H1 / miRNA-
21 / biotin-H2 / SA-ALP (curve red), and MBs / CP H1 / miRNA-21 / biotin-H2 / biotin-
H1 / SA-ALP (curve blue). HCR, hybridization chain reaction; EIM, enzyme-induced 
metallization; MA, AuNPs-modified ITO microelectrode array; MBs, magnetic 
nanobeads; CP, capture probe; SA-ALP, streptavidin-alkaline phosphatase 





















Figure 9. (A) Schematic diagram of the electrochemical miRNA biosensor based on 
enzyme-free signal amplification integrating rGO-PPy/AuNPs, CHA, and HCR. (B) 
Structures of H1, target, H2, H3, and H4, respectively. (C) DPVs for the detection of 
different concentrations of target microRNA with the proposed method. (D) The 
corresponding calibration plot obtained from the DPVs shown in (C). rGO, reduced 
graphene oxide; PPy, polypyrrole; AuNPs, gold nanoparticles; CHA, catalytic hairpin 
assembly; HCR, hybridization chain reaction. Adapted from Ref. [46], Copyright 






































Figure 10. Scheme for the electrochemical quantification of miRNA-21 through the 
target-driven CHA and ratiometric amplification strategy. Reprinted from Ref. [48], 














Figure 11. (A) Schematic diagram of exosomal miRNA detection using a “sandwich” 
electrochemical exosomal miRNA sensor (SEEmiR). In the presence of target, 
electrode surface-assembled PNA probes specifically hybridize with SNA−miRNA 
complex. RuHex serves as an electroactive indicator by CC. (B) CVs (a) and CC 
curves (b) of the SEEmiR sensor assembled with PNA probe (gray line), after 
hybridization with miRNA in the absence (green line) and presence (orange line) of 
SNA after incubation with RuHex, respectively. ΔQ is the variation in the redox 
charge of RuHex before and after hybridization. (c) SWVs of PNA and DNA 
hybridization with miRNA-21 labeled with MB. From inset, PNA−miRNA shows a 
substantial signal enhancement over DNA−miRNA. (d) Optimization of assembly 
concentrations of PNA to obtain rational probe spacing at the interface and to 
maintain the maximal hybridization efficiency for SNA. (C) (a) CC curves of the 
SEEmiR sensor in response to different target miRNA-21 concentrations in the 
presence of SNA after incubation with RuHex. (b) ΔQ versus miRNA-21 
concentrations. (c) CC curves of the SEEmiR sensor in response to different target 
miRNA-21 concentrations without SNA amplification. (d) Linear relationship between 
ΔQ and the logarithm of target miRNA-21 concentrations in the presence (orange 
line) and absence (blue line) of SNA amplification, respectively. (d) SNA renders the 
sensitivity improvement by 3 orders of magnitude (gray box). PNA, peptide nucleic 
acid; SNA, spherical nucleic acid; RuHex, [Ru(NH3)6]3+; CC, chronocoulometry; MB, 
methylene blue. Adapted with permission from Ref. [51]. Copyright 2019 American 














Figure 12. Schematic illustration of the ratiometric electrochemical biosensor for 
exosomal miRNA-21 detection. Reprinted from Ref. [56], Copyright (2020), with 




























Figure 13. Schematic illustration of the preparation of the SH-RNA/MCH-AuNPs-
SPCEs and the direct competitive hybridization assay developed for miRNA 
















Table 1. Comparison of the analytical performance of the most relevant electrochemical miRNAs biosensors developed 




Non-amplified miRNAs electrochemical biosensors   
Target Detection Method Platform  LOD LR Real sample Ref. 
miRNA-21 DPV GCE/PLLY/MB-DNA/LNA 
 
2.3 fM 10 fM-70 fM Exosomes samples [56] 
miRNA-21 Amperometry SPCE/AuNPs/RNA-SH 
 
25 fM 100 fM-25 pM MCF-7 and MCF-10 [57] 
miRNA-21 EIS 
DPV 
PGE/PPy/DNA 12.25 nM  
0.17 nM 












miRNA-21 DPV FTO/CGO/Au-PtBNPs/SA/CP 
 
1.0 fM 1.0 fM-1.0 µM Human serum [61] 
miRNA-21 DPV GCE/MoS2@MB 
 
68 fM, 0.1 pM-1.0 nM Human serum [62] 
miRNA-122 DPV Au/GO/PB  
 
1.5 fM 10 fM-10 nM Human serum [63] 
miRNA-21 SWV GCE/AuNPs/Thi/MoS2 
 
0.26 pM 1.0 pM-10 nM Human serum [64] 
miRNA-103 SWV GCE/AuNPs/SH-JUG-MHA/pDNA-103 
 
100 fM 100 fM-5.0 nM - [65] 
miRNA-21 DPV AuNS/ssRNA/TB 
 
78 aM 100 aM-1.0 nM Human serum [66] 
miRNA-21 CV Au/PPy/AgNF/PNA 
 
10 fM 1.0 x 10-13 M-1.0 x 10-8 M Human plasma [67] 











Amplification-based miRNAs electrochemical biosensors  
 
Target Detection Method Signal Amplification Strategy Electrode LOD LR Real sample Ref. 
miRNA-21 Chronocoulometry Graphene oxide-loaded iron oxide. Signal of 
[Ru(NH3)6]3+ catalyzed by[Fe(CN)6]3- 





miR-107 Chronocoulometry Gold-loaded nanoporous superparamagnetic iron oxide 
nanocubes (Au@NPFe2O3NC). Catalytic reduction of 
[Ru(NH3)6]3+ 








AuNPs-decorated MoS2 nanosheet (AuNPs@MoS2) as 
electrode modifier and signal-amplifier element. 
Reduction current of [Ru(NH3)6]3+ or charge transfer 
resistance of [Fe(CN)6]3-/4-. 
 
GCE 7.08 fM 
0.45 fM 
10 fM-1.0 nM 
1.0 fM-1.0 nM 
Human serum [24] 
miRNA-21 Chronocoulometry [Ru(NH3)6]3+ accumulated at the hybrid between the 
capture thiolated-DNA immobilized at MoS2 nanosheets 
intimately coupled with electrodeposited AuNPs 
(AuNPs@MoS2) 
 
SPE 100 aM 10 fM-10 pM - [25] 
miR-29a-3p Chronocoulometry DSN-mediated hydrolysis of the DNA-1 strand at the 
(DNA-1/miRNA-29a-3p) surface heteroduplex, target 
release, decrease of the amount of (DNA-1/DNA-2-
AuNPs) surface hybrid.  Decrease of 
[Ru(NH3)6]3+electrostatically associated to this hybrid 
 
Au 0.05 fM 0.1 fM-100 pM Cells from healthy 
and infected 
patients with 
H1N1 influenza A 
virus 
[27] 
miRNA-21 Chronocoulometry Triple signal amplification based on target-triggered 
cyclic DSN digestion and bridge DNA−AuNPs and 
preconcentration of  [Ru(NH3)6]3+.  
 
Au 6.8 aM 1.0 x 10-17 M-1.0 x 10-11 
M 
Human serum  
 
[28] 
miRNA let-7d SWV Double-loop hairpin probe and doxorubicin-loaded 
AuNPs (AuNPs@Dox)  
 
Au 0.17 pM 1.0 pM-10 nM Human serum [29] 
miRNA-21 Amperometry Hairpin DNA modified-gold electrode, DSN-assisted 
target recycling, and DNA/streptavidin-AuNPs to anchor 
the biotinylated HRP 
 
Au 43 aM 0.1 fM-100 pM A549 tumor cells [30] 
miRNA-21 
 
DPV MWCNTs@GONRs/AuNPs with DSN assisted target 
recycling and alkaline phosphatase-induced redox 
reactions 
GCE 0.034 fM 1.0 x 10-16 M-1.0 x 10-10 
M 












miRNA-21 SWV Star-trigon structure and endonuclease mediated signal 
amplification using PDDA and AuNPs to anchor the MB 
labeled-capture probe. 
 
GCE 30 aM 100 aM-1.0 nM Human serum [32] 
miRNA-24 SWV Cobalt oxide petals and poly(o-phenylenediamine) and 
covalent attachment of hyaluronic acid and methionine-
gold nanoclusters as support of the “partial” probe/MB-
reporter double strand. 
 
GCE 33.3 fM 100 fM-0.1 µM Cancer cells [33] 
miRNA-141 DPV 
EIS 
AuNPs and a hairpin-locked DNAzyme, generation of 
the “active” DNAzyme and successive activation cycles, 
and the fragments on the electrode surface capture 
produced numerous bioconjugates CuCo−CeO2-
signaling DNA. 
 
GCE 33 aM 0.1 fM-10 nM Human prostate-
cancer and HeLa 
cells 
[34] 
miRNA-21 EIS Neutravidin and a highly specific biotinylated DNA/LNA 
molecular beacon probe conjugated with AuNPs 
 
GCE 0.3 pM 1.0 pM-1000 pM Human serum [35] 
miRNA let-7a DPV Formation of trivalent DNAzyme junctions from the 
miRNA that initiated CHA of three hairpins into many 
trivalent DNAzyme junctions and subsequent generation 
of G-quadruplex 
 
Au 0.46 fM 1.0 fM-1.0 nM Human serum [36] 
miRNA-21 CV MB mediated by Ir(III) complex intercalated at the 
surface generated G-quadruplex 
 
Au 1.6 fM 5.0 fM-1.0 pM Human serum [37] 
miRNA-21 Amperometry Tetrahedral DNA nanostructures and G-quadruplex and 
hemin as a catalyst for TBM oxidation 
 
Au 176 fM 500 fM-10 nM Human serum [38] 
miRNA-21 DPV Signal cascade amplification of DNA walkers 
 
Au 67 aM 0.1 fM-100.0 fM MCF-7 cells [39] 
miRNA-21 SWV MB released from mesoporous silica nanospheres-
hairpin H1, based on the enzyme-free amplification of 
CHA and HCR 
 




miRNA-21 SWV Phosphate backbone DNA strand and molybophosphate 
as redox probe 
 
Au 0.5 fM 1.0 fM-1.0 nM Human serum [41] 
miRNA-21 DPV HCR and EIM, catalytic activity ALP 
 









miRNA-21 DPV Hairpin capture probe immobilized at Fe3O4 allowing 
HCR and the synergized catalytic reduction of hydrogen 
peroxide/TMB system in the presence of a Cu(II) planar 
complex 
 
MGCE 33 aM 100 aM-100 nM Human serum [43] 
miRNA-21 DPV Cascade HCR as an enzyme-free isothermal with the 
intercalation of MB in the hyper-branched resulting 
dsDNA 
 
Au 11 pM 30 pM-7.0 nM Human serum [44] 
miRNA-141 
miRNA-21 
DPV Fe3O4-NPs modified with thionine and ferrocene and 
target-triggered HCR 
 
Au 0.44 fM 
0.46 fM 
1.0 fM-1.0 nM Human breast 
cancer cells 
[45] 
miRNA-16 DPV AuNPs/PPy-rGO, CHA and HCR 
 
GCE 1.57 fM 10 fM-5.0 nM Human serum [46] 
miRNA-21 EIS ZrO2-rGO-modified electrode coupled with CHA GCE 4.3 x 10-15 
M 
1.0 x 10-14 M-1.0 x 10-10 
M 





miRNA-21 SWV Ratiometric scheme based on target driven CHA 
mismatched using three hairpins, H1, Fc-H2 with 2 
mismatches and a thiolated-MB modified-H3 
 
Au 1.1 fM 5.0 fM-0.1 nM Cell extraction 
samples from  
MCF-7 
[48] 
miRNA-21 DPV A conjugate ALP-Streptavidin and the detection from the 
naphtol oxidation signal in the presence of α-naphtyl 
phosphate 
 
PGE 100 pM 200 pM-388 nM - [49] 
miRNA-21 DPV DNA-AuNPs, miRNA-21 and MWCNTs modified with 
a signaling DNA and labeled with thionine 
 
GCE 0.032 pM 0.1 pM-12000 pM - [50] 
miRNA-21 Chronocoulometry A sandwich" electrochemical exosomal microRNA 
sensor using peptide nucleic acid as biorecognition 
element and spherical DNA as secondary probe 
 
Au 49 aM 100 aM-1.0 nM MCF-7 and HeLa 
cells 
[51] 
miRNA-21 DPV Sandwich hybridization between thiolated-DNA probes 
at SPCE modified with GO-AuNPs nanohybrid and the 
signaling DNA conjugated with Fc-AuNPs-Streptavidin 
 
SPCE 5 fM 10 fM-2.0 pM Human serum [52] 
miRNA-21 DPV RCA that produced a massive G-rich long ssDNAs to be 
used as matrix for the in situ synthesis of PdNPs  
 
Au 8.6 aM 50 aM-100 fM Human serum [53] 
miRNA-21 Amperometry Anti DNA-RNA antibody anti DNA probe-miRNA 
heteroduplex and bacterial protein A (ProtA) conjugated 




































DPV COF nanowire and melamine as platform for 
immobilizing the capture ssDNAs able to hybridize with 
the aptamers anti-miRNA155 and anti-miRNA-22 
modified with shell-encoded AuNPs as signal labels 
 
GCE 6.7 fM 
1.5 fM 














Amplification-based miRNAs electrochemical biosensors  
 
Target Detection Method Signal Amplification Strategy Electrode LOD LR Real sample Ref. 
miRNA-21 Chronocoulometry Graphene oxide-loaded iron oxide. Signal of 
[Ru(NH3)6]3+ catalyzed by[Fe(CN)6]3- 





miR-107 Chronocoulometry Gold-loaded nanoporous superparamagnetic iron oxide 
nanocubes (Au@NPFe2O3NC). Catalytic reduction of 
[Ru(NH3)6]3+ 








AuNPs-decorated MoS2 nanosheet (AuNPs@MoS2) as 
electrode modifier and signal-amplifier element. 
Reduction current of [Ru(NH3)6]3+ or charge transfer 
resistance of [Fe(CN)6]3-/4-. 
 
GCE 7.08 fM 
0.45 fM 
10 fM-1.0 nM 
1.0 fM-1.0 nM 
Human serum [24] 
miRNA-21 Chronocoulometry [Ru(NH3)6]3+ accumulated at the hybrid between the 
capture thiolated-DNA immobilized at MoS2 nanosheets 
intimately coupled with electrodeposited AuNPs 
(AuNPs@MoS2) 
 
SPE 100 aM 10 fM-10 pM - [25] 
miR-29a-3p Chronocoulometry DSN-mediated hydrolysis of the DNA-1 strand at the 
(DNA-1/miRNA-29a-3p) surface heteroduplex, target 
release, decrease of the amount of (DNA-1/DNA-2-
AuNPs) surface hybrid.  Decrease of 
[Ru(NH3)6]3+electrostatically associated to this hybrid 
 
Au 0.05 fM 0.1 fM-100 pM Cells from healthy 
and infected 
patients with 
H1N1 influenza A 
virus 
[27] 
miRNA-21 Chronocoulometry Triple signal amplification based on target-triggered 
cyclic DSN digestion and bridge DNA−AuNPs and 
preconcentration of  [Ru(NH3)6]3+.  
 
Au 6.8 aM 1.0 x 10-17 M-1.0 x 10-11 
M 
Human serum  
 
[28] 
miRNA let-7d SWV Double-loop hairpin probe and doxorubicin-loaded 
AuNPs (AuNPs@Dox)  
 
Au 0.17 pM 1.0 pM-10 nM Human serum [29] 
miRNA-21 Amperometry Hairpin DNA modified-gold electrode, DSN-assisted 
target recycling, and DNA/streptavidin-AuNPs to anchor 
the biotinylated HRP 
 
Au 43 aM 0.1 fM-100 pM A549 tumor cells [30] 
miRNA-21 
 
DPV MWCNTs@GONRs/AuNPs with DSN assisted target 
recycling and alkaline phosphatase-induced redox 
reactions 
GCE 0.034 fM 1.0 x 10-16 M-1.0 x 10-10 
M 











miRNA-21 SWV Star-trigon structure and endonuclease mediated signal 
amplification using PDDA and AuNPs to anchor the MB 
labeled-capture probe. 
 
GCE 30 aM 100 aM-1.0 nM Human serum [32] 
miRNA-24 SWV Cobalt oxide petals and poly(o-phenylenediamine) and 
covalent attachment of hyaluronic acid and methionine-
gold nanoclusters as support of the “partial” probe/MB-
reporter double strand. 
 
GCE 33.3 fM 100 fM-0.1 µM Cancer cells [33] 
miRNA-141 DPV 
EIS 
AuNPs and a hairpin-locked DNAzyme, generation of 
the “active” DNAzyme and successive activation cycles, 
and the fragments on the electrode surface capture 
produced numerous bioconjugates CuCo−CeO2-
signaling DNA. 
 
GCE 33 aM 0.1 fM-10 nM Human prostate-
cancer and HeLa 
cells 
[34] 
miRNA-21 EIS Neutravidin and a highly specific biotinylated DNA/LNA 
molecular beacon probe conjugated with AuNPs 
 
GCE 0.3 pM 1.0 pM-1000 pM Human serum [35] 
miRNA let-7a DPV Formation of trivalent DNAzyme junctions from the 
miRNA that initiated CHA of three hairpins into many 
trivalent DNAzyme junctions and subsequent generation 
of G-quadruplex 
 
Au 0.46 fM 1.0 fM-1.0 nM Human serum [36] 
miRNA-21 CV MB mediated by Ir(III) complex intercalated at the 
surface generated G-quadruplex 
 
Au 1.6 fM 5.0 fM-1.0 pM Human serum [37] 
miRNA-21 Amperometry Tetrahedral DNA nanostructures and G-quadruplex and 
hemin as a catalyst for TBM oxidation 
 
Au 176 fM 500 fM-10 nM Human serum [38] 
miRNA-21 DPV Signal cascade amplification of DNA walkers 
 
Au 67 aM 0.1 fM-100.0 fM MCF-7 cells [39] 
miRNA-21 SWV MB released from mesoporous silica nanospheres-
hairpin H1, based on the enzyme-free amplification of 
CHA and HCR 
 




miRNA-21 SWV Phosphate backbone DNA strand and molybophosphate 
as redox probe 
 
Au 0.5 fM 1.0 fM-1.0 nM Human serum [41] 
miRNA-21 DPV HCR and EIM, catalytic activity ALP 
 









miRNA-21 DPV Hairpin capture probe immobilized at Fe3O4 allowing 
HCR and the synergized catalytic reduction of hydrogen 
peroxide/TMB system in the presence of a Cu(II) planar 
complex 
 
MGCE 33 aM 100 aM-100 nM Human serum [43] 
miRNA-21 DPV Cascade HCR as an enzyme-free isothermal with the 
intercalation of MB in the hyper-branched resulting 
dsDNA 
 
Au 11 pM 30 pM-7.0 nM Human serum [44] 
miRNA-141 
miRNA-21 
DPV Fe3O4-NPs modified with thionine and ferrocene and 
target-triggered HCR 
 
Au 0.44 fM 
0.46 fM 
1.0 fM-1.0 nM Human breast 
cancer cells 
[45] 
miRNA-16 DPV AuNPs/PPy-rGO, CHA and HCR 
 
GCE 1.57 fM 10 fM-5.0 nM Human serum [46] 
miRNA-21 EIS ZrO2-rGO-modified electrode coupled with CHA GCE 4.3 x 10-15 
M 
1.0 x 10-14 M-1.0 x 10-10 
M 





miRNA-21 SWV Ratiometric scheme based on target driven CHA 
mismatched using three hairpins, H1, Fc-H2 with 2 
mismatches and a thiolated-MB modified-H3 
 
Au 1.1 fM 5.0 fM-0.1 nM Cell extraction 
samples from  
MCF-7 
[48] 
miRNA-21 DPV A conjugate ALP-Streptavidin and the detection from the 
naphtol oxidation signal in the presence of α-naphtyl 
phosphate 
 
PGE 100 pM 200 pM-388 nM - [49] 
miRNA-21 DPV DNA-AuNPs, miRNA-21 and MWCNTs modified with 
a signaling DNA and labeled with thionine 
 
GCE 0.032 pM 0.1 pM-12000 pM - [50] 
miRNA-21 Chronocoulometry A sandwich" electrochemical exosomal microRNA 
sensor using peptide nucleic acid as biorecognition 
element and spherical DNA as secondary probe 
 
Au 49 aM 100 aM-1.0 nM MCF-7 and HeLa 
cells 
[51] 
miRNA-21 DPV Sandwich hybridization between thiolated-DNA probes 
at SPCE modified with GO-AuNPs nanohybrid and the 
signaling DNA conjugated with Fc-AuNPs-Streptavidin 
 
SPCE 5 fM 10 fM-2.0 pM Human serum [52] 
miRNA-21 DPV RCA that produced a massive G-rich long ssDNAs to be 
used as matrix for the in situ synthesis of PdNPs  
 
Au 8.6 aM 50 aM-100 fM Human serum [53] 
miRNA-21 Amperometry Anti DNA-RNA antibody anti DNA probe-miRNA 
heteroduplex and bacterial protein A (ProtA) conjugated 













LOD: limit of detection; LR: linear range; SPCE: screen-printed carbon electrode; EIS: electrochemical impedance spectroscopy; DPV: differential pulse voltammetry; AuNPs: gold nanoparticles; GCE: 
glassy carbon electrode; DNA: deoxyribonucleic acid; SPE: screen-printed electrode; DSN: duplex specific nuclease; SWV: square wave voltammetry; HRP: horseradish peroxidase; MWCNTs@GONRs: 
multi-walled carbon nanotubes@graphene oxide nanoribons; PDDA: poly(diallyldimethylammonium) chloride;  MB: methylene blue; LNA: locked nucleic acid; CHA: catalytic hairpin assembly; CV: 
cyclic voltammetry; TBM: 3,3’,5,5’-tetramethylbenzidine; HCR: hybridization chain reaction; EIM: enzyme-induced metallization; ASV: anodic stripping voltammetry; MGCE: magnetic glassy carbon 
electrode; Fe3O4-NPs: magnetite nanoparticles; Au/PPy-rGO: polypyrrole-reduced graphene oxide; rGO: reduced graphene oxide; MCF7: human breast cancer cell lines; PdNPs: palladium nanoparticles; 
AgNC: silver nanocluster; ALP: alkaline phosphatase; PGE: pencil graphite electrode; MWCNTs: multi-walled carbon nanotubes; GO: graphene oxide; Fc: ferrocene; RCA: rolling circle amplification; 
ssDNA: single-stranded DNA; COF: covalent–organic framework. 
 
 
LOD: limit of detection; LR: linear range; DPV: differential pulse voltammetry; GCE: glassy carbon electrode; PLLY: polylysine; MB-DNA: methylene blue-modified DNA probe; LNA: locked nucleic 
acid; SPCE: screen-printed carbon electrode; AuNPs: gold nanoparticles; MCF-7: human breast cancer cell lines; MCF-10: non-tumorigenic epithelial breast cell line; EIS: electrochemical impedance 
spectroscopy; PGE: pencil graphite electrode; PPy: polypyrrole; HUH-7: human liver cell line; NrGO-CHIT:  nitrogen doped reduced graphene oxide-chitosan; SWV: square wave voltammetry; ITO: 
indium tin oxide; PAA: poly(acrylic acid); RuHex: hexaammineruthenium(III) chloride; FTO: fluorine tin oxide; CGO: carboxylated graphene oxide; Au-PtBNPs: Au-Pt bimetallic nanoparticles; SA: 
streptavidin; CP: capture probe; GO: graphene oxide; PB: prussian blue; Thi: thionine; SH-JUG: 5-hydroxy-3-hexanedithiol-1,4-naphthoquinone; MHA: 6-mercaptohexanoic acid; AuNS: gold nanoparticles 
superlattices; ssRNA: single-stranded RNA; TB: toluidine blue; AgNF: silver nanofoam; PNA: peptide nucleic acid; SPE: screen-printed electrode. 
 
TABLE 1. Comparison of the analytical performance of the most relevant electrochemical miRNAs biosensors developed 
between 2017 and the beginning of 2020.  
 
 





DPV COF nanowire and melamine as platform for 
immobilizing the capture ssDNAs able to hybridize with 
the aptamers anti-miRNA155 and anti-miRNA-22 
modified with shell-encoded AuNPs as signal labels 
 
GCE 6.7 fM 
1.5 fM 
0.01 pM-1000 pM Human serum [55] 
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